-
1
-
-
40449096647
-
Strategies for managing today's infections
-
Carmeli Y. Strategies for managing today's infections. Clin Microbiol Infect 14 Suppl 3 (2008) 22-31
-
(2008)
Clin Microbiol Infect
, vol.14
, Issue.SUPPL. 3
, pp. 22-31
-
-
Carmeli, Y.1
-
2
-
-
40449128870
-
Evolving problems with resistant pathogens
-
Chastre J. Evolving problems with resistant pathogens. Clin Microbiol Infect 14 Suppl 3 (2008) 3-14
-
(2008)
Clin Microbiol Infect
, vol.14
, Issue.SUPPL. 3
, pp. 3-14
-
-
Chastre, J.1
-
3
-
-
39049134890
-
Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species
-
Gupta V. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species. Expert Opin Investig Drugs 17 (2008) 131-143
-
(2008)
Expert Opin Investig Drugs
, vol.17
, pp. 131-143
-
-
Gupta, V.1
-
4
-
-
9544247854
-
Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection
-
Bergeron J., Ammirati M., Danley D., James L., Norcia M., Retsema J., et al. Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection. Antimicrob Agents Chemother 40 (1996) 2226-2228
-
(1996)
Antimicrob Agents Chemother
, vol.40
, pp. 2226-2228
-
-
Bergeron, J.1
Ammirati, M.2
Danley, D.3
James, L.4
Norcia, M.5
Retsema, J.6
-
5
-
-
23644449559
-
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004)
-
Fritsche T.R., Sader H.S., Stilwell M.G., Dowzicky M.J., and Jones R.N. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004). Diagn Microbiol Infect Dis 52 (2005) 195-201
-
(2005)
Diagn Microbiol Infect Dis
, vol.52
, pp. 195-201
-
-
Fritsche, T.R.1
Sader, H.S.2
Stilwell, M.G.3
Dowzicky, M.J.4
Jones, R.N.5
-
6
-
-
38049141883
-
Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections
-
Townsend M.L., Pound M.W., and Drew R.H. Tigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infections. Ther Clin Risk Manag 3 (2007) 1059-1070
-
(2007)
Ther Clin Risk Manag
, vol.3
, pp. 1059-1070
-
-
Townsend, M.L.1
Pound, M.W.2
Drew, R.H.3
-
7
-
-
67349167812
-
-
Wyeth Pharmaceuticals Inc, Philadelphia, PA: Wyeth Pharmaceuticals Inc;, Accessed 06.08.08
-
® product insert. Philadelphia, PA: Wyeth Pharmaceuticals Inc; 2007. http://www.wyeth.com/hcp/tygacil (Accessed 06.08.08).
-
(2007)
® product insert
-
-
-
8
-
-
40549101032
-
Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the Tigecycline Evaluation and Surveillance Trial
-
Rodloff A.C., Leclercq R., Debbia E.A., Cantón R., Oppenheim B.A., and Dowzicky M.J. Comparative analysis of antimicrobial susceptibility among organisms from France, Germany, Italy, Spain and the UK as part of the Tigecycline Evaluation and Surveillance Trial. Clin Microbiol Infect 14 (2008) 307-314
-
(2008)
Clin Microbiol Infect
, vol.14
, pp. 307-314
-
-
Rodloff, A.C.1
Leclercq, R.2
Debbia, E.A.3
Cantón, R.4
Oppenheim, B.A.5
Dowzicky, M.J.6
-
9
-
-
0003344510
-
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard
-
National Committee for Clinical Laboratory Standards, 6th ed, Wayne, PA: NCCLS;
-
National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 6th ed. Document M7-A6. Wayne, PA: NCCLS; 2003.
-
(2003)
Document
-
-
-
10
-
-
33646696219
-
-
Clinical and Laboratory Standards Institute, 16th ed. Document M100-S16. Wayne, PA: CLSI;
-
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 16th ed. Document M100-S16. Wayne, PA: CLSI; 2006.
-
(2006)
Performance standards for antimicrobial susceptibility testing
-
-
-
11
-
-
0037626394
-
MYSTIC Study Group (Europe). The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000
-
Turner P.J., and Greenhalgh J.M. MYSTIC Study Group (Europe). The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000. Clin Microbiol Infect 9 (2003) 563-567
-
(2003)
Clin Microbiol Infect
, vol.9
, pp. 563-567
-
-
Turner, P.J.1
Greenhalgh, J.M.2
-
12
-
-
4544327051
-
ARPAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe
-
Van Looveren M., and Goossens H. ARPAC Steering Group. Antimicrobial resistance of Acinetobacter spp. in Europe. Clin Microbiol Infect 10 (2004) 684-704
-
(2004)
Clin Microbiol Infect
, vol.10
, pp. 684-704
-
-
Van Looveren, M.1
Goossens, H.2
-
13
-
-
54049101716
-
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae
-
Vasilev K., Reshedko G., Orasan R., Sanchez M., Teras J., Babinchak T., et al. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae. J Antimicrob Chemother 62 Suppl 1 (2008) i29-40
-
(2008)
J Antimicrob Chemother
, vol.62
, Issue.SUPPL. 1
-
-
Vasilev, K.1
Reshedko, G.2
Orasan, R.3
Sanchez, M.4
Teras, J.5
Babinchak, T.6
-
14
-
-
0141925608
-
In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therapy
-
Wenzel R.P., Sahm D.F., Thornsberry C., Draghi C.D., Jones M.E., and Karlowsky J.A. In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000-2001 to expanded-spectrum cephalosporins and comparator antimicrobials: implications for therapy. Antimicrob Agents Chemother 47 (2003) 3089-3098
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 3089-3098
-
-
Wenzel, R.P.1
Sahm, D.F.2
Thornsberry, C.3
Draghi, C.D.4
Jones, M.E.5
Karlowsky, J.A.6
-
15
-
-
37249052710
-
Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe
-
Cantón R., Novais A., Valverde A., Machado E., Peixe L., Baquero F., et al. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 14 Suppl 1 (2008) 144-153
-
(2008)
Clin Microbiol Infect
, vol.14
, Issue.SUPPL. 1
, pp. 144-153
-
-
Cantón, R.1
Novais, A.2
Valverde, A.3
Machado, E.4
Peixe, L.5
Baquero, F.6
-
16
-
-
38949157167
-
Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15
-
Coque T.M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 14 (2008) 195-200
-
(2008)
Emerg Infect Dis
, vol.14
, pp. 195-200
-
-
Coque, T.M.1
Novais, A.2
Carattoli, A.3
Poirel, L.4
Pitout, J.5
Peixe, L.6
-
17
-
-
0035984795
-
Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae
-
Dabernat H., Delmas C., Seguy M., Pelissier R., Faucon G., Bennamani S., et al. Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 46 (2002) 2208-2218
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 2208-2218
-
-
Dabernat, H.1
Delmas, C.2
Seguy, M.3
Pelissier, R.4
Faucon, G.5
Bennamani, S.6
-
18
-
-
24044504090
-
Susceptibility of European β-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003
-
Fluit A.C., Florijn A., Verhoef J., and Milatovic D. Susceptibility of European β-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. J Antimicrob Chemother 56 (2005) 133-138
-
(2005)
J Antimicrob Chemother
, vol.56
, pp. 133-138
-
-
Fluit, A.C.1
Florijn, A.2
Verhoef, J.3
Milatovic, D.4
-
19
-
-
34447256788
-
Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime
-
García-Cobos S., Campos J., Lázaro E., Román F., Cercenado E., Garciá-Rey C., et al. Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob Agents Chemother 51 (2007) 2564-2573
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 2564-2573
-
-
García-Cobos, S.1
Campos, J.2
Lázaro, E.3
Román, F.4
Cercenado, E.5
Garciá-Rey, C.6
-
20
-
-
21444442865
-
Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae β-lactam resistance by using site-directed mutagenesis and gene recombinants
-
Osaki Y., Sanbongi Y., Ishikawa M., Kataoka H., Suzuki T., Maeda K., et al. Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae β-lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob Agents Chemother 49 (2005) 2834-2839
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 2834-2839
-
-
Osaki, Y.1
Sanbongi, Y.2
Ishikawa, M.3
Kataoka, H.4
Suzuki, T.5
Maeda, K.6
-
21
-
-
4444271222
-
Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002
-
Tiemersma E.W., Bronzwaer S.L., Lyytikäinen O., Degener J.E., Schrijnemakers P., Bruinsma N., et al. Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 10 (2004) 1627-1634
-
(2004)
Emerg Infect Dis
, vol.10
, pp. 1627-1634
-
-
Tiemersma, E.W.1
Bronzwaer, S.L.2
Lyytikäinen, O.3
Degener, J.E.4
Schrijnemakers, P.5
Bruinsma, N.6
-
22
-
-
34248513134
-
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centres (2005)
-
Sader H.S., Watters A.A., Fritsche T.R., and Jones R.N. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centres (2005). BMC Infect Dis 7 (2007) 9
-
(2007)
BMC Infect Dis
, vol.7
, pp. 9
-
-
Sader, H.S.1
Watters, A.A.2
Fritsche, T.R.3
Jones, R.N.4
-
23
-
-
48649085107
-
Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis
-
Chou Y.Y., Lin T.Y., Lin J.C., Wang N.C., Peng N.Y., and Chang F.Y. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. J Microbiol Immunol Infect 41 (2008) 124-129
-
(2008)
J Microbiol Immunol Infect
, vol.41
, pp. 124-129
-
-
Chou, Y.Y.1
Lin, T.Y.2
Lin, J.C.3
Wang, N.C.4
Peng, N.Y.5
Chang, F.Y.6
-
24
-
-
34948851810
-
Risk factors for development of multiple-class resistance to Streptococcus pneumoniae strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location
-
Van Eldere J., Mera R.M., Miller L.A., Poupard J.A., and Amrine-Madsen H. Risk factors for development of multiple-class resistance to Streptococcus pneumoniae strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location. Antimicrob Agents Chemother 51 (2007) 3491-3497
-
(2007)
Antimicrob Agents Chemother
, vol.51
, pp. 3491-3497
-
-
Van Eldere, J.1
Mera, R.M.2
Miller, L.A.3
Poupard, J.A.4
Amrine-Madsen, H.5
-
25
-
-
21444451421
-
Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003
-
Reinert R.R., Reinert S., van der Linden M., Cil M.Y., Al-Lahham A., and Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 49 (2005) 2903-2913
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 2903-2913
-
-
Reinert, R.R.1
Reinert, S.2
van der Linden, M.3
Cil, M.Y.4
Al-Lahham, A.5
Appelbaum, P.6
-
26
-
-
9444250412
-
Emerging resistance among bacterial pathogens in the intensive care unit-a European and North American Surveillance study (2000-2002)
-
Jones M.E., Draghi D.C., Thornsberry C., Karlowsky J.A., Sahm D.F., and Wenzel R.P. Emerging resistance among bacterial pathogens in the intensive care unit-a European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob 3 (2004) 14
-
(2004)
Ann Clin Microbiol Antimicrob
, vol.3
, pp. 14
-
-
Jones, M.E.1
Draghi, D.C.2
Thornsberry, C.3
Karlowsky, J.A.4
Sahm, D.F.5
Wenzel, R.P.6
-
27
-
-
23644449109
-
Tigecycline Evaluation and Surveillance Trial (TEST Program) Group. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004)
-
Hoban D.J., Bouchillon S.K., Johnson B.M., Johnson J.L., and Dowzicky M.J. Tigecycline Evaluation and Surveillance Trial (TEST Program) Group. In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004). Diagn Microbiol Infect Dis 52 (2005) 215-227
-
(2005)
Diagn Microbiol Infect Dis
, vol.52
, pp. 215-227
-
-
Hoban, D.J.1
Bouchillon, S.K.2
Johnson, B.M.3
Johnson, J.L.4
Dowzicky, M.J.5
|